CD200 and cancer: While rare variants affecting the mitochondrially encoded MRC complex I (NADH:CoQ oxidoreductase) genes have been described in cancer18–20 and recently in AML21, a comprehensive analysis of rare variants affecting the 86 nuclear-encoded MRC genes has not been performed in cancer cohorts.